VDF Futureceuticals, Inc. v. Stiefel Labs, Inc., No. 14-3232 (7th Cir. 2015)
Annotate this CaseVDF has trademark and patent rights in “CoffeeBerry” extract and licensed J&J to make and sell CoffeeBerry-based skin-care products. VDF was entitled to “running royalties,” based on the number of sales by the licensee, or by sublicensees. The license permitted J&J to sublicense its rights and required J&J to pay a minimum quarterly royalty if running royalties fell below a specified level. The license could not be assigned without written permission, but it did not forbid a change of control of J&J. J&J sublicensed Stiefel, a manufacturer of dermatological products. Four years later, J&J’s owners sold their interests to Stiefel for $8.5 million. J&J became a Stiefel subsidiary. After buying J&J’s stock, Stiefel engineered amended the sublicence, reducing the alternative minimum royalties that Stiefel owed J&J and diverting part of the license-revenue stream from VDF and J&J to Stiefel. VDF filed suit, alleging de facto assignment and breach of contract. The Seventh Circuit affirmed summary judgment in favor of the defendants with respect to claims that they engineered an unauthorized assignment of the license and that the $8.5 million paid for J&J was really a purchase of J&J’s anticipated sales revenue, so that part of that revenue should have gone to VDF as advance royalties.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.